Literature DB >> 2364444

Aggregated immunoglobulin and Fc fragment of IgG induce IL-6 release from human monocytes.

Z D Ling1, H J Ziltener, B T Webb, D S Matheson.   

Abstract

The Fc fragment of immunoglobulin (Ig) has been shown to play an important role in the regulation of humoral immunity, cellular immunity, lymphocyte and monocyte activation, and immune mediator secretion. We wished to determine if Ig or Fc fragments would induce IL-6 production from monocytes. Incubation of monocytes purified from human peripheral blood mononuclear cells with aggregated Ig or Fc fragments of Ig induced interleukin-6 (IL-6) activity in the supernatants. Monomeric Ig taken from an intravenous preparation of Ig, from which all aggregated Ig are removed, would not induce IL-6 production from monocytes whereas as a heat-treated aliquot, presumably containing aggregates, did induce IL-6. The supernatants were assayed according to their ability to induce growth in a murine hybridoma cell line B9, or enhance Ig secretion of B cells stimulated with Staphylococcus aureus Cowan 1 (SAC). The IL-6 activity in the supernatants could be neutralized by a polyclonal rabbit anti-human IL-6 antiserum in both assays of IL-6 activity. Exposure of T-enriched or B-enriched lymphocyte subpopulations to Fc fragments did not induce the release of any IL-6 after 12 hr of incubation, but small amounts of IL-6 were produced by B-enriched cells after 60 hr of exposure to Fc fragments. Hence Fc fragments and aggregated Ig induce peripheral blood monocytes to rapidly secrete large quantities of interleukin-6.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2364444     DOI: 10.1016/0008-8749(90)90189-x

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

1.  Spontaneous labour at term is associated with fetal monocyte activation.

Authors:  A Steinborn; C Sohn; C Sayehli; A Baudendistel; D Hüwelmeier; C Solbach; E Schmitt; M Kaufmann
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

2.  A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab')2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation.

Authors:  D Nachbaur; M Herold; B Eibl; H Glassl; H Schwaighofer; C Huber; A Gächter; M Pichl; D Niederwieser
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

3.  Physical Characterization and Innate Immunogenicity of Aggregated Intravenous Immunoglobulin (IGIV) in an In Vitro Cell-Based Model.

Authors:  E M Moussa; J Kotarek; J S Blum; E Marszal; E M Topp
Journal:  Pharm Res       Date:  2016-04-01       Impact factor: 4.200

4.  Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?

Authors:  Vinayakumar Siragam; Davor Brinc; Andrew R Crow; Seng Song; John Freedman; Alan H Lazarus
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

Review 5.  Interleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defense.

Authors:  L Graeve; M Baumann; P C Heinrich
Journal:  Clin Investig       Date:  1993-08

6.  Intravenous immunoglobulin induces interferon-gamma and interleukin-6 in vivo.

Authors:  Z D Ling; E Yeoh; B T Webb; K Farrell; J Doucette; D S Matheson
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

7.  Elevated monocyte interleukin-6 (IL-6) production in immunosuppressed trauma patients. I. Role of Fc gamma RI cross-linking stimulation.

Authors:  G Szabo; K Kodys; C L Miller-Graziano
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

8.  Different types of FCgamma-receptors are involved in anti-Lewis Y antibody induced effector functions in vitro.

Authors:  M Dettke; H Loibner
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

9.  A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal.

Authors:  Ajit Rayamajhi; Sam Nightingale; Nisha Keshary Bhatta; Rupa Singh; Rachel Kneen; Elizabeth Ledger; Krishna Prasad Bista; Penny Lewthwaite; Chandeshwar Mahaseth; Lance Turtle; Jaimie Sue Robinson; Sareen Elizabeth Galbraith; Malgorzata Wnek; Barbara Wilmot Johnson; Brian Faragher; Michael John Griffiths; Tom Solomon
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

10.  Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics.

Authors:  Marisa K Joubert; Meghana Deshpande; Jane Yang; Helen Reynolds; Christine Bryson; Mark Fogg; Matthew P Baker; Jonathan Herskovitz; Theresa J Goletz; Lei Zhou; Michael Moxness; Gregory C Flynn; Linda O Narhi; Vibha Jawa
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.